Developed at Johns Hopkins University

The data and intelligence layer for functional health

Functional decline predicts hospitalization better than any vital sign. We measure it.

Request a PilotExplore Pebl One
Scroll
Functional Health Intelligence·Clinical-Grade Precision·IRB-Approved Research·Longitudinal Monitoring·11 Clinical Markets·Reimbursement Ready·Incubated at Johns Hopkins·100% Founder-Owned IP·Functional Health Intelligence·Clinical-Grade Precision·IRB-Approved Research·Longitudinal Monitoring·11 Clinical Markets·Reimbursement Ready·Incubated at Johns Hopkins·100% Founder-Owned IP·
The Problem

Medicine can't manage what it can't measure

Functional decline is the strongest predictor of hospitalization, falls, and loss of independence. Yet clinicians measure it with subjective scales and lab equipment that never leaves the clinic — like diagnosing heart disease by taking a pulse once every six months.


By the time decline is visible, the window for intervention has already closed.

$50B+
Annual cost of falls in the United States
20%+
Inter-rater variability in clinical scales
4×
Typical annual assessment frequency
6M+
Americans with neurodegenerative disease
The Shift

From broken tools to clinical intelligence

Subjective scales
→
Objective Pebl Score
Annual clinic visits
→
Continuous home monitoring
$5K–$50K lab equipment
→
Handheld. Under 60 seconds.
Pebl One

Four modalities. One device.
Under 60 seconds.

Clinical-grade functional assessment. No wearables. No setup. Just pick it up.

Pebl One
clinical-grade handheld
4
Modalities
<60s
Assessment
365+
Data Points / Year
11
Clinical Markets
The Platform

Hardware captures data.
The Aging Health Graph creates value.

Pebl One captures. The Aging Health Graph compounds.

Patient trajectory over 12 months
With Pebl
Without Pebl
STABLEMONITORINTERVENEDETECTED WITH PEBLM1M3M5M7M9M11M12
Caught early. Returned to baseline.
Undetected. Irreversible by month 10.
The Pebl Score

Every patient scored. Every risk visible.

87
Stable
Continue monitoring
58
Monitor
Increase frequency
31
Intervene
Immediate review
One prevented fall saves $30K–$50K
The Clinical Experience

Measure. Detect. Act.

Pebl.Clinical Dashboard
34
Pebl Score
A. Patel, 79
Intervene
Significant decline — immediate review recommended
Parkinson'sPeripheral Neuropathy
Grip
2.8kg
▼ 38%
Tremor
6.8Hz
▲ Elevated
VPT
18.6V
▼ Severe
Reaction
486ms
▲ Slowed
Grip Force — 90 Day
Clinical Markets

One platform. Eleven addressable markets.

All with existing reimbursement pathways. Tap any market to learn more.

Pilot Programs

Three tiers. One platform.

Deploy Pebl across care facilities, clinical research, or enterprise — each with full platform access and dedicated onboarding.

Care Facility

SNFs, ALFs, and outpatient clinics
  • Up to 50 assessments/month
  • Dashboard access
  • Dedicated onboarding
  • Monthly reports
Contact for Inquiry →
Recommended

Enterprise

Health systems and large networks
  • Unlimited assessments
  • Full platform + API access
  • Custom integrations
  • Dedicated success manager
Contact for Inquiry →

Clinical Research

IRB-approved studies and trials
  • Up to 100 assessments/month
  • IRB-compliant data exports
  • Co-authorship pathway
  • Research API access
Contact for Inquiry →
The Team

Built by researchers. Backed by clinicians.

Ibrahim Jehanzeb
Ibrahim Jehanzeb
Founder & CEO
Johns Hopkins · Welch Center · Clinical research and epidemiology
Tarik Metin
Tarik Metin
Co-Founder & CTO
Intertrek · Full hardware architecture · Embedded systems and PCB design
Mohammed Siam
Mohammed Siam
Founding Software Engineer
3× Google · Search and Ads · Firmware, data pipelines, frontend
Johns Hopkins UniversityGoogleWelch CenterIntertek
Get Started

Your patients' health is a story.
Don't miss a chapter.

Deploy Pebl One in your facility. Join our clinical pilot program and help build the dataset that will transform how medicine understands functional health.